Effect of Huishengkoufuye on Plasma Fibrinogen and Blood Platelet in Patients with Advanced Non-small Cell Lung Cancer
Jia You-cha
Abstract
Jia You-cha
Abstract
Objective: To stdudy the effect of Huishengkoufuye on plasma fibrinogen and blood platelet in patients with advanced non-small cell lung cancer. Methods: 112 cases of advanced non-small cell lung disease patient who had been treated in our hospital from January 2011 to July 2013, divided into two groups randomly, the treat group(60 cases) and the control group(52 cases), the treat group gave Huishengkoufuye to treat patients on the basis of support and symptomatic treatment, while the control group only gave support and symptomatic treatment. After four weeks,observed the change of plasma fibrinogen and blood platelet levels of the two groups after two different treatment methods. Results: After medicine treatment,the level of plasma fibrinogen and blood platelet of the treat group was similar to before,the difference has no statistically significance(P0.05); the level of plasma fibrinogen and blood platelet of the control group was higher than before, the difference has statistically significance(P0.05); the level of plasma fibrinogen and blood platelet of treat group was lower than control group, the difference has statistically significance(P0.05). Conclusions: Huishengkoufuye might improve the state of blood hypercoagulability by decrease the content of plasma fibrinogen and blood platelet.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To stdudy the effect of Huishengkoufuye on plasma fibrinogen and blood platelet in patients with advanced non-small cell lung cancer. Methods: 112 cases of advanced non-small cell lung disease patient who had been treated in our hospital from January 2011 to July 2013, divided into two groups randomly, the treat group(60 cases) and the control group(52 cases), the treat group gave Huishengkoufuye to treat patients on the basis of support and symptomatic treatment, while the control group only gave support and symptomatic treatment. After four weeks,observed the change of plasma fibrinogen and blood platelet levels of the two groups after two different treatment methods. Results: After medicine treatment,the level of plasma fibrinogen and blood platelet of the treat group was similar to before,the difference has no statistically significance(P0.05); the level of plasma fibrinogen and blood platelet of the control group was higher than before, the difference has statistically significance(P0.05); the level of plasma fibrinogen and blood platelet of treat group was lower than control group, the difference has statistically significance(P0.05). Conclusions: Huishengkoufuye might improve the state of blood hypercoagulability by decrease the content of plasma fibrinogen and blood platelet.
Key concepts: Fibrinogen, Medicine, Platelet, Internal medicine, Lung cancer, Gastroenterology, Clinical significance, Blood plasma